Join us now & support harm reduction!

    We respect your privacy. Unsubscribe at anytime.
    Latest
    News

    Switching to vapes beneficial for smokers with heart disease, landmark study finds

    Ali Anderson
    Ali Anderson
    October 28, 2024
    4 min
    Download Source FilesDownload Source Files

    Switching to vaping from smoking leads to significantly less fatal and life-threatening cardiac events in people with heart disease, a landmark new study has shown. 

    The study from South Korea, published in the European Heart Journal, found that switching to vapes was equally as beneficial as quitting smoking entirely without using any alternatives. 

    The report said: “..switching to e-cigarettes was associated with a significantly lower risk of MACE (Major Adverse Coronary Event) than continued combustible cigarette use, similar to quitting smoking.” 

    Researchers followed a group of almost 18,000 adult smokers who had been diagnosed with coronary artery disease (CAD). 

    They had all undergone percutaneous coronary intervention (PCI) - a non-surgical procedure that improves blood flow to the heart by opening blocked coronary arteries.

    Following the PCI, almost half (49.8 per cent) of the group continued to smoke, 9.4 per cent switched to vapes (either alongside cigarettes or exclusively), and 40.7 per cent successfully quit smoking.

    Risk of fatal or life-threatening events lower among vapers

    After a follow up of up to 4.5 years, the percentage of people who had suffered a MACE was significantly lower among those who either switched to vaping or quit smoking entirely than in those who continued to smoke. 

    For patients who continued to smoke, it was 17 per cent. Meanwhile, for those who switched to vapes (either exclusively or alongside cigarettes), it was 10.8 per cent and for those who quit altogether it was 13.4 per cent.

    Source: European Heart Journal (2024) 00, 1–12 https://doi.org/10.1093/eurheartj/ehae705

    The number of MACEs was even lower among those who switched exclusively to vaping (9.6 per cent), compared to those who both smoked and vaped (12.2 per cent). 

    Source: "European Heart Journal (2024) 00, 1–12 https://doi.org/10.1093/eurheartj/ehae705

    Switching to vapes a ‘viable alternative’

    The report noted that less than half of the patients managed to successfully quit smoking after treatment for CAD, for which smoking is a key risk factor.

    It said: “First, although successful quitting smoking after PCI was associated with a significantly lower risk of MACE than continued combustible cigarette use, only 40.7 per cent of the patients quit smoking after PCI. 

    “Second, patients switching to e-cigarettes used markedly fewer combustible cigarettes than those who continued combustible cigarette use [alone], which may have contributed to the reduced risk of MACE.

    “Third, patients who completely switched to e-cigarettes after PCI had significantly lower risks of MACE than dual users.”

    It added: “ These findings suggest that switching to e-cigarettes could be a viable alternative for patients who find it challenging to quit combustible cigarettes after PCI.”

    The report said that although the best strategy for smokers undergoing PCI is to stop smoking altogether, switching to vapes at least some of the time is worth considering for patients unable to quit.

    Dr Konstantinos Farsalinos, a cardiologist and research fellow at the Onassis Cardiac Surgery Center in Athens, Greece, said the study should help lay to rest the misconception that nicotine is a risk factor for heart disease. 

    He said: “This study will be the beginning of the end for the misconception that nicotine use is a strong risk factor for cardiovascular disease, a misconception that is widely spread not only among non-experts but also among healthcare professionals.”

    He said the findings contradict a recent controversial study that suggests vaping carries the same cardiovascular risk as smoking. 

    “It also exposes the problematic recent metanalysis [where data from multiple studies is combined] which claimed that e-cigarettes confer the same cardiovascular risk as smoking, a metanalysis that will soon be heavily criticised in a paper that is currently under review,” he said.

    Dr Farsalinos added that the study also highlights how difficult smokers can find it to quit, even after being diagnosed with smoking-related cardiovascular disease.

    He said: “I can imagine that many healthcare professionals have strongly condemned any attempt of such patients to quit smoking with the help of e-cigarettes. This means that fewer patients had the chance to make a lifestyle change that would benefit their health.”

    Take Action Now!

    Sign up to our newsletter to get important news and alerts as it happens

    By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

    FAQs

    Campaigning can be difficult, especially if it's not your full time job, but we're here to make it simpler. In this section, you'll find answers to frequently asked questions about legislative processes, advocacy strategies, and how you can effectively participate in shaping policies.

    What is advocacy and how can I get involved?

    Simply put, advocacy is organising a group of likeminded people who campaign for a change in government policy by talking to the people in power. This can take many forms, from posting on social media, to writing to your local politicians, to arranging meetings with the government or responding to consultations. We help by providing the information and tools you need to do this effectively.

    How can I track the progress of legislation?

    Government websites will usually contain a list of the legislative files that are in the process of becoming law. However, these kinds of websites are designed for legal and political professionals, and they can often be confusing for the general public. We help by keeping our ear to the ground, looking out for development in tobacco harm reduction proposals, and then make sure you have an easy-to-use summary.

    What's the best way to contact my representatives?

    Politicians are people too, and like everyone else, the best way to get messages to them varies from person to person. Some like email or even traditional mail, while others are constantly checking their social media feeds. They all have one thing in common though: they need to keep up to date with what matters to the people they represent. We help you find yours by keeping databases of politicians and candidates across Europe alongside all of their contact details, so you can quickly find out how to reach the person you need.

    Can I make a difference?

    Yes! The only reason that harm reduction is still alive and kicking in Europe today is because people like you, with no political or campaigning background, took action to protect the availability of the products they rely on to stay smoke free. We've got lots of articles that talk about when and how this has happened in the past, which we hope will inspire you to get involved and make a difference.

    Still have questions?

    Send us an email and we'll get back to you.

    Stay Updated with Our Newsletter

    Sign up for our newsletter to receive regular updates and stay engaged.

    By joining, you agree to our Terms and Conditions.
    Be part of something great

    Join the community

    Make a positive change in the world of tobacco harm reduction
    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.
    Email
    Please fill out the form below to get in touch with us.
    hello@clearingtheair.eu